Cargando…
Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysis
BACKGROUND: Primary hyperoxaluria (PH) is a family of rare, life-threatening genetic liver disorders characterized by elevated production and excretion of oxalate. To date, the clinical and economic burden associated with PH has not been well characterized due to the rarity of the disease and previo...
Autores principales: | Mucha, Lisa, Hoppe, Bernd, Silber, Abigail, Wang, Zheng, Miyasato, Gavin, Skaar, Jeffrey R, Langman, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373026/ https://www.ncbi.nlm.nih.gov/pubmed/35199581 http://dx.doi.org/10.18553/jmcp.2022.28.3.316 |
Ejemplares similares
-
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria
por: Ariceta, Gema, et al.
Publicado: (2021) -
Improving Treatment Options for Primary Hyperoxaluria
por: Hoppe, Bernd, et al.
Publicado: (2022) -
Is stiripentol truly effective for treating primary hyperoxaluria?
por: Martin-Higueras, Cristina, et al.
Publicado: (2020) -
Kidney Stones in Primary Hyperoxaluria: New Lessons Learnt
por: Jacob, Dorrit E., et al.
Publicado: (2013) -
ALLN-177, oral enzyme therapy for hyperoxaluria
por: Lingeman, James E., et al.
Publicado: (2019)